SCHEMBL26051694

SCHEMBL26051694

O=Cc1cc2ccnc(Cl)c2n2ncnc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ DAPK3 O43293 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ RET P07949 1/20 0.33
▸ MET P08581 1/20 0.33
▸ PDGFRB P09619 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ PRKACA P17612 1/20 0.33
▸ FLT1 P17948 1/20 0.33
▸ LTK P29376 1/20 0.33
▸ KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22902442 0.78 SMN1; SMN2 (0.40) ALDH1A1CHEK1AURKADAPK3JAK2
SCHEMBL26051758 0.78 HAVCR2 (0.38) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL22902872 0.77 MAP2K1 (0.38) CHEK1AURKADAPK3JAK2MAP4K4
SCHEMBL22902514 0.71 NPC1 (0.41) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL29523025 0.71 NPC1 (0.41) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL12365545 0.67 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL12537593 0.67 ERN1 (0.31) —
SCHEMBL14537332 0.67 CYP1A2 (0.32) CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL23755342 0.65 RXFP1 (0.37) ALDH1A1DYRK1AKDM4E
SCHEMBL29942068 0.65 RXFP1 (0.37) ALDH1A1DYRK1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3999508-B1 TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2023-08-30 — — EP disclosed
Send feedback